Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor
Identificadores
Identificadores
Data de publicación
2013Título da revista
Clinical & Translational Oncology
Tipo de contido
Artigo